Zidovudine and interferon therapy for adult T-cell leukaemia/lymphoma: Results of a preliminary study at UHWI-Mona

West Indian Medical Journal

Volumn 45, Issue 4, 1996, Pages 107-109

  Wharfe, G ^a   Hanchard, B ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; INTERFERON; ZIDOVUDINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; FLU LIKE SYNDROME; HUMAN; MALE; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; T CELL LEUKEMIA; T CELL LYMPHOMA; THROMBOCYTOPENIA;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERFERONS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; ZIDOVUDINE;

EID: 0030469043     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bunn, P, and Foon K.A. (1985) Therapeutic options in advanced cutaneous T-cell lymphomas: A role for interferon α- 2α. Seminars in Oncology, 12: (Suppl. 5) 18-24.
2. Gill, P.S., Harrington, W., Kaplan, M. et al. (1995). Treatment of adult T-cell leukaemia-lymphoma with a combination of interferon α and zidovudine. New Engl. J. Med. 332: 1744-1748.
3. Gill, P.S., Masood, R., Cai, J. et al. (1992). Novel (antiviral) therapy for adult T-cell leukaemia secondary to HTLV-1 infection. Blood, 80: 74a.
4. Hanchard, B., Gibbs, W. and Lofters, W. (1990). ATL in Jamaica. In; Human Retrovirology, 173 - 183.
5. Hermine, O., Didier, B. and Gessain, A., (1995). Briefreport: treatment of adult T-cell leukaemia-lymphoma with zidovudine and interferon a. New Engl. J. Med. 332: 1749-1751.
6. Isono, T., Ogawa, K and Seto, A. (1990). Antiviral effect of Zidovudine in the experimental model of adult T-cell leukaemia inrabbits. Leuk. Res. 14: 941-947.
7. Karnofsky, D., Abelmann, W. and Kraver, L. et al. (1984). The use of nitrogen mustards in the palliative treatment of carcinoma with particular reference to bronchogenic carcinoma. Cancer, 634-669.
8. Lymphoma Study Group (1984 - 1987) (1991) Major prognostic factors of patients with ATL: A cooperative study. Leukemia Res. 15: 81-90.
9. Matisushita, S., Mitsuya, H., Reitz, M.S., and Broder, S. (1987). Pharmacological inhibition of in vitro infectivity of human T-lymphotropic virus type 1. J. Clinical Investigation 80: 394-400.
10. Oka, T., Ohtsuki, Y., Funhata, M. and Miyoshi, I. (1990). Suppressive effects of interferons on the production and release of human T-lymphotropic virus type 1 (HTLV-1) Arch. Virol. 115:63-73.
11. Shibata, D., Brynes, R.K., Rabinourtz, A. et al. (1989). Human T-cell lymphotrophic virustype 1 (HTLV-1) associated AdultT-cell leukaemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1). Ann. Int. Med. 111: 871-875.
12. Shimoyama, M., Ota, K., Kikuchi, M. et al. (1988). Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkins lymphoma treated with VEPA or VEPA-M. J. Clin. Oncol.6: 128-141.
13. Tamura, K., Makino, S., Araki, T., Imamura, T. and Seita, M. (1987). Recombinant interferon beta and gamma in the treatment of adult T-cell leukaemia. Cancer, 59: 1059-1062.
14. Thestrup-Pederse, K. (1990) Interferon therapy in cutaneousT-cell lymphoma. Curr. Prob. Dermatol. Basil Karger. 19: 258-263.